國立虎尾科技大學 |

Artificial Intelligence Methods for Discovery in Large Biobanks.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Artificial Intelligence Methods for Discovery in Large Biobanks./
作者:	Yang, Lu.
面頁冊數:	1 online resource (193 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-06, Section: A.
Contained By:	Dissertations Abstracts International85-06A.
標題:	Medicine. -
電子資源:	click for full text (PQDT)
ISBN:	9798381021370

Artificial Intelligence Methods for Discovery in Large Biobanks.
Yang, Lu.

Artificial Intelligence Methods for Discovery in Large Biobanks. - 1 online resource (193 pages)

Source: Dissertations Abstracts International, Volume: 85-06, Section: A.

Thesis (Ph.D.)--Stanford University, 2023.

Includes bibliographical references

Large-scale biobanks, housing vast genetic and phenotypic data, are driving scientific discoveries across a wide range of diseases. However, harnessing the full potential of biobanks requires innovative methodologies that address challenges in phenotype recognition, genetic association studies, and multimorbidity. First, in order to define the disease cohorts accurately, we must recognize phenotypes that may not be labelled in the primary data. To address this challenge, we developed an AI-based method called POPDx (Population-based Objective Phenotyping by Deep Extrapolation) that computes disease liabilities for 12,803 ICD-10 codes and 1538 Phenotype codes for all participants in the UK Biobank. Second, the genetic data in biobanks are often used to conduct association studies in order to understand the genetic architecture of key health traits. These studies are commonly set up as case-control, but the "healthy" may evolve over time and become cases. We demonstrate that our disease liability estimates from patient phenotyping allow us to improve downstream genetic discovery by mapping disease risk to a quantitative scale that provides greater statistical power compared to the dichotomous designs. Finally, multimorbidity (the coexistence of multiple diseases in an individual) provides an opportunity to understand disorders that may share genetic or environmental risk factors. Therefore, we present ForeSITE (Forecasting Susceptibility to Illness with Transformer Embeddings), an automatic framework powered by a GPT-style architecture that models disease trajectories and can predict likely future diseases. These new capabilities, both alone and in combination, enhance the utility of large-scale biobanks for scientific discoveries. In particular, our contributions to phenotype recognition, genetic association studies, and multimorbidity modeling pave the way for improved disease understanding and personalized healthcare interventions.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798381021370Subjects--Topical Terms:

644133
Medicine.
Index Terms--Genre/Form:

554714
Electronic books.

Artificial Intelligence Methods for Discovery in Large Biobanks.
LDR:03237ntm a22003617 4500 001 1151184
005 20241104055821.5
006 m o d
007 cr bn ---uuuuu
008 250605s2023 xx obm 000 0 eng d
020 $a 9798381021370
035 $a (MiAaPQ)AAI30726833
035 $a (MiAaPQ)STANFORDjn115rp0937
035 $a AAI30726833
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Yang, Lu. $3 1069219
245 1 0 $a Artificial Intelligence Methods for Discovery in Large Biobanks.
264 0 $c 2023
300 $a 1 online resource (193 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-06, Section: A.
500 $a Advisor: Altman, Russ B.;Jure, Jure.
502 $a Thesis (Ph.D.)--Stanford University, 2023.
504 $a Includes bibliographical references
520 $a Large-scale biobanks, housing vast genetic and phenotypic data, are driving scientific discoveries across a wide range of diseases. However, harnessing the full potential of biobanks requires innovative methodologies that address challenges in phenotype recognition, genetic association studies, and multimorbidity. First, in order to define the disease cohorts accurately, we must recognize phenotypes that may not be labelled in the primary data. To address this challenge, we developed an AI-based method called POPDx (Population-based Objective Phenotyping by Deep Extrapolation) that computes disease liabilities for 12,803 ICD-10 codes and 1538 Phenotype codes for all participants in the UK Biobank. Second, the genetic data in biobanks are often used to conduct association studies in order to understand the genetic architecture of key health traits. These studies are commonly set up as case-control, but the "healthy" may evolve over time and become cases. We demonstrate that our disease liability estimates from patient phenotyping allow us to improve downstream genetic discovery by mapping disease risk to a quantitative scale that provides greater statistical power compared to the dichotomous designs. Finally, multimorbidity (the coexistence of multiple diseases in an individual) provides an opportunity to understand disorders that may share genetic or environmental risk factors. Therefore, we present ForeSITE (Forecasting Susceptibility to Illness with Transformer Embeddings), an automatic framework powered by a GPT-style architecture that models disease trajectories and can predict likely future diseases. These new capabilities, both alone and in combination, enhance the utility of large-scale biobanks for scientific discoveries. In particular, our contributions to phenotype recognition, genetic association studies, and multimorbidity modeling pave the way for improved disease understanding and personalized healthcare interventions.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Medicine. $3 644133
650 4 $a Information science. $3 561178
650 4 $a Genetics. $3 578972
650 4 $a Celiac disease. $3 968501
650 4 $a Genotype & phenotype. $3 1372654
650 4 $a Biobanks. $3 1066079
650 4 $a Missing data. $3 1468189
650 4 $a Chronic illnesses. $3 1437672
650 4 $a Cohort analysis. $3 894116
650 4 $a Rare diseases. $3 1021157
650 4 $a Multiple sclerosis. $3 582232
650 4 $a Electronic health records. $3 1467061
650 4 $a Patients. $3 963142
650 4 $a User interface. $3 1049517
650 4 $a Comorbidity. $3 677577
655 7 $a Electronic books. $2 local $3 554714
690 $a 0800
690 $a 0369
690 $a 0723
690 $a 0564
710 2 $a Stanford University. $3 1184533
710 2 $a ProQuest Information and Learning Co. $3 1178819
773 0 $t Dissertations Abstracts International $g 85-06A.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30726833 $z click for full text (PQDT)